methyl 2-(thiazol-2-ylcarbamoyl)acetate | 58199-15-8

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: methyl 2-(thiazol-2-ylcarbamoyl)acetate
• 英文别名: N-thiazol-2-yl-malonamic acid methyl ester；N-Thiazol-2-yl-malonamic acid methyl ester；methyl 3-oxo-3-(1,3-thiazol-2-ylamino)propanoate
• CAS: 58199-15-8
• 化学式: C₇H₈N₂O₃S
• 分子量: 200.218
• InChiKey: XIYOPROLJLPDTN-UHFFFAOYSA-N

物化性质

• 密度：
  1.412±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  96.5
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl 2-(thiazol-2-ylcarbamoyl)acetate 在 lithium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 生成 N-thiazol-2-ylmalonamic acid
  参考文献：
  名称：

  Novel malonamide derivatives as potent κ opioid receptor agonists

  摘要：

  A novel series of malonamide derivatives was synthesized. These amides were shown to be potent and selective kappa opioid receptor agonists. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.01.053
• 作为产物：
  描述：

  7-hydroxy-5H-thiazolo[3,2-a]pyrimidin-5-one 、 甲醇 在 acid 作用下， 生成 methyl 2-(thiazol-2-ylcarbamoyl)acetate
  参考文献：
  名称：

  Dashkevich,L.B. et al., Journal of Organic Chemistry USSR (English Translation), 1975, vol. 11, p. 2230 - 2234

  摘要：

  DOI：

文献信息

• Inhibitors of VEGF receptor and HGF receptor signaling
  申请人：Saavedra Mario Oscar

  公开号：US20070004675A1

  公开（公告）日：2007-01-04

  The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions

  该发明涉及抑制VEGF受体信号和HGF受体信号。该发明提供了抑制VEGF受体信号和HGF受体信号的化合物和方法。该发明还提供了治疗细胞增殖性疾病和病况的组合物和方法。
• Synthesis, antiarrhythmic and anticoagulant activities of novel thiazolo derivatives from methyl 2-(thiazol-2-ylcarbamoyl)acetate
  作者：Abd El-Galil E. Amr、Nermien M. Sabrry、Mohamed M. Abdalla、Bakr F. Abdel-Wahab

  DOI：10.1016/j.ejmech.2008.05.004

  日期：2009.2

  A series of novel thiazolo derivatives 2–17 were synthesized by initial condensation of methyl 2-(thiazol-2-ylcarbamoyl)acetate 1 with phenyl isothiocyanate and further reactions using different organic reagents. The structures of newly synthesized compounds were confirmed by IR, 1H NMR, EIMS spectral data and elemental analysis. Initially the acute toxicity of the compounds was assayed via the determination

  一系列新颖的噻唑并衍生物2 - 17由2-（噻唑-2-基氨基甲酰基）乙酸酯的初始缩合合成1用不同的有机试剂异硫氰酸苯酯和进一步的反应。通过IR，1 H NMR，EIMS光谱数据和元素分析确认了新合成的化合物的结构。最初，化合物的急性毒性是通过确定其LD 50来测定的。筛选所有化合物的抗心律不齐和抗凝活性，与普鲁卡因酰胺和利多卡因作为阳性对照相比，它们显示出较高的抗心律不齐活性。详细的合成，光谱数据，LD 50 并报道了合成化合物的药理活性。
• Amide derivatives and methods of their use
  申请人：Dolle E. Roland

  公开号：US20050107355A1

  公开（公告）日：2005-05-19

  Amide derivatives of the general formulae Ia and Ib: are disclosed. Pharmaceutical compositions containing these compounds, and methods for their use, inter alia, for treating and/or preventing gastrointestinal disorders, pain, and pruritus are also disclosed.

  一般式Ia和Ib的酰胺衍生物已被披露。还披露了含有这些化合物的药物组合物，以及用于治疗和/或预防胃肠道疾病、疼痛和瘙痒等的方法。
• INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING
  申请人：Saavedra Oscar Mario

  公开号：US20120083482A1

  公开（公告）日：2012-04-05

  The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds of general formula (A) wherein A 1 is sulfur, A 3 is CH, A 2 is CH, D is heterocycle, Z is oxygen, SO 0-2 or NR, Ar is phenyl and G is not a ring, and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  本发明涉及抑制VEGF受体信号和HGF受体信号的技术。本发明提供了通式（A）的化合物，其中A1为硫，A3为CH，A2为CH，D为杂环，Z为氧，SO0-2或NR，Ar为苯基，G不是环，并提供了抑制VEGF受体信号和HGF受体信号的方法。本发明还提供了治疗细胞增殖性疾病和病情的组合物和方法。
• Synthesis and reactions of thiosemicarbazides, triazoles, and Schiff bases as antihypertensive α-blocking agents
  作者：Bakr F. Abdel-Wahab、Salwa F. Mohamed、Abd El-Galil E. Amr、Mohamed M. Abdalla

  DOI：10.1007/s00706-008-0896-2

  日期：2008.9

  Methyl 2-(thiazol-2-ylcarbamoyl)acetate was synthesized and used as starting material. It was treated with hydrazine hydrate to afford the hydrazide, which was reacted with nitromethane and formaldehyde to give the saturated nitropyrimidine. The hydrazide was reacted with phenyl isothiocyanate to afford the thiosemicarbazide, which was cyclized with ethyl bromoacetate, sodium hydroxide, or sulfuric acid to afford N-phenylthiazolidinone, N-phenyltriazole, and thiadiazolyl derivatives. The methyl 2-(thiazol-2-ylcarbamoyl)acetate was coupled with diazonium salts of aniline, 4-chloroaniline, 4-bromoaniline, or 4-aminobenzenesulfonamide to afford the carbamoyl acetates, which were reacted with 2-aminobenzimidazole, 1,2,4,5-tetrachlorophthalic anhydride, and hydrazine hydrate to afford the corresponding thiazolylmalonamide, tetrachloroisoindolylimide, and tri-azole derivatives. Schiff bases and imides are newly synthesized candidates obtained via simple condensation of the hydrazide with aldehydes, 2,3-pyridinedicarboxylic anhydride, or 1,8-naphthalenedicarboxylic anhydride. The pharmacological screening showed that many of these compounds have good antihypertensive alpha-blocking activity and low toxicity.